Showing results (11-20 of 71) with videos related to
Sort By:
Pageof 8
Journal of Clinical Pharmacology|September 22, 2020
Therapeutic Protein Drug Interaction Potential in Subjects With Psoriasis: An Assessment Based on Population Pharmacokinetic Analyses of Sensitive Cytochrome P450 Probe SubstratesAbhishek G Sathe, Ahmed A Othman, Mohamed-Eslam F MohamedJournal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 8, 2008
Determination of mycophenolic acid glucuronide in microsomal incubations using high performance liquid chromatography-tandem mass spectrometryMohamed-Eslam F Mohamed, Stephen S Harvey, Reginald F FryeThe AAPS Journal|October 2, 2023
Applications of Modeling and Simulation Approaches in Support of Drug Product Development of Oral Dosage Forms and Locally Acting Drug Products: a Symposium SummaryEleftheria Tsakalozou, Mohamed-Eslam F Mohamed, Sebastian Polak, et al.Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 29, 2014
Inhibitory effect of six herbal extracts on CYP2C8 enzyme activity in human liver microsomesAhmed A Albassam, Mohamed-Eslam F Mohamed, Reginald F FryeCureus|June 22, 2026
Extensive Emphysematous Necrotising Pancreatitis Presenting With Cullen's Sign Despite a Normal Serum Amylase LevelWael Abdelgawwad, Mohamed Eslam, Rawan Honeini, et al.The AAPS Journal|March 1, 2022
Utility of Modeling and Simulation Approach to Support the Clinical Relevance of Dissolution Specifications: a Case Study from Upadacitinib DevelopmentMohamed-Eslam F Mohamed, Insa Winzenborg, Ahmed A Othman, et al.Dermatology Online Journal|April 5, 2021
Targetoid lesions in a patient with systemic lupus erythematosusRasheen Imtiaz, Cheyenne Hornback, Mohamed Eslam, et al.Journal of Clinical Pharmacology|November 6, 2020
Exposure-Response Analyses for Upadacitinib Efficacy in Subjects With Atopic Dermatitis-Analyses of Phase 2b Study to Support Selection of Phase 3 DosesMohamed-Eslam F Mohamed, Sathej Gopalakrishnan, Henrique D Teixeira, et al.Clinical Pharmacology and Therapeutics|October 9, 2019
Exposure-Response Analyses for Upadacitinib Efficacy and Safety in the Crohn's Disease CELEST Study and Bridging to the Extended-Release FormulationMohamed-Eslam F Mohamed, Ben Klünder, Ana P Lacerda, et al.Clinical Pharmacology and Therapeutics|June 14, 2019
Exposure-Response Analyses of Upadacitinib Efficacy in Phase II Trials in Rheumatoid Arthritis and Basis for Phase III Dose SelectionMohamed-Eslam F Mohamed, Ben Klünder, Heidi S Camp, et al.Pageof 8